Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05298683
Title A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hellenic Society of Hematology
Indications
Therapies
Age Groups: adult | senior
Covered Countries GRC


No variant requirements are available.